Dierickx D, Habermann TM. Post-transplantation lymphoproliferative disorders in adults. N Engl J Med. 2018;378(6):549–62. https://doi.org/10.1056/NEJMra1702693.

Article  CAS  PubMed  Google Scholar 

Atallah-Yunes SA, Salman O, Robertson MJ. Post-transplant lymphoproliferative disorder: update on treatment and novel therapies. Br J Haematol. 2023;201(3):383–95. https://doi.org/10.1111/bjh.18763.

Article  CAS  PubMed  Google Scholar 

Møller MB, Pedersen NT, Christensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation–a population-based study of 1575 cases. Br J Haematol. 2004;124(2):151–9. https://doi.org/10.1046/j.1365-2141.2003.04749.x.

Article  PubMed  Google Scholar 

Morgans AK, Reshef R, Tsai DE. Posttransplant lymphoproliferative disorder following kidney transplant. Am J Kidney Dis. 2010;55(1):168–80. https://doi.org/10.1053/j.ajkd.2009.09.026.

Article  PubMed  Google Scholar 

Fujimi A, Nagamachi Y, Yamauchi N, Onoyama N, Hayasaka N, Matsuno T, et al. High-grade B-cell lymphoma, not otherwise specified, presenting as primary peritoneal lymphomatosis and successfully treated with dose-adjusted EPOCH-R. J Clin Exp Hematop. 2024;64(1):37–44. https://doi.org/10.3960/jslrt.23044.

Article  PubMed  PubMed Central  Google Scholar 

Ichikawa S, Fukuhara N, Saito K, Onodera K, Onishi Y, Yokoyama H, et al. Diffuse large b-cell lymphoma presenting as peritoneal lymphomatosis: a case report and literature review. Intern Med. 2022;61(13):2057–60. https://doi.org/10.2169/internalmedicine.8793-21.

Article  PubMed  Google Scholar 

Curakova E, Genadieva-Dimitrova M, Misevski J, Caloska-Ivanova V, Andreevski V, Todorovska B, et al. NonHodgkin’s lymphoma with peritoneal localization. Case Rep Gastrointest Med. 2014;2014: 723473. https://doi.org/10.1155/2014/723473.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Glazer HS, Lee JK, Balfe DM, Mauro MA, Griffith R, Sagel SS. Non-Hodgkin lymphoma: computed tomographic demonstration of unusual extranodal involvement. Radiology. 1983;149(1):211–7. https://doi.org/10.1148/radiology.149.1.6225145.

Article  CAS  PubMed  Google Scholar 

Kim HB, Hong R, Na YS, Choi WY, Park SG, Lee HJ. Isolated peritoneal lymphomatosis defined as post-transplant lymphoproliferative disorder after a liver transplant: a case report. World J Clin Cases. 2019;7(24):4299–306. https://doi.org/10.12998/wjcc.v7.i24.4299.

Article  PubMed  PubMed Central  Google Scholar 

O’Neill AC, Shinagare AB, Rosenthal MH, Tirumani SH, Jagannathan JP, Ramaiya NH. Differences in CT features of peritoneal carcinomatosis, sarcomatosis, and lymphomatosis: retrospective analysis of 122 cases at a tertiary cancer institution. Clin Radiol. 2014;69(12):1219–27. https://doi.org/10.1016/j.crad.2014.06.019.

Article  PubMed  Google Scholar 

Weng SC, Wu CY. Lymphoma presenting as peritoneal lymphomatosis with ascites. J Chin Med Assoc. 2008;71(12):646–50. https://doi.org/10.1016/s1726-4901(09)70009-7.

Article  PubMed  Google Scholar 

Kim YG, Baek JY, Kim SY, Lee DH, Park WS, Kwon Y, et al. Peritoneal lymphomatosis confounded by prior history of colon cancer: a case report. BMC Cancer. 2011;11:276. https://doi.org/10.1186/1471-2407-11-276.

Article  PubMed  PubMed Central  Google Scholar 

Hazarika N, Dhabhar B, Saikia TK. Highly elevated serum CA 125 in a lady with ascites and retroperitoneal mass–a diagnostic dilemma. J Assoc Physicians India. 2008;56:47–8.

PubMed  Google Scholar 

Lynch MA, Cho KC, Jeffrey RB Jr, Alterman DD, Federle MP. CT of peritoneal lymphomatosis. AJR Am J Roentgenol. 1988;151(4):713–5. https://doi.org/10.2214/ajr.151.4.713.

Article  CAS  PubMed  Google Scholar 

Stallone G, Infante B, Grandaliano G. Management and prevention of post-transplant malignancies in kidney transplant recipients. Clin Kidney J. 2015;8(5):637–44. https://doi.org/10.1093/ckj/sfv054.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fuhrmann JD, Valkova K, von Moos S, Wüthrich RP, Müller TF, Schachtner T. Cancer among kidney transplant recipients >20 years after transplantation: post-transplant lymphoproliferative disorder remains the most common cancer type in the ultra long-term. Clin Kidney J. 2022;15(6):1152–9. https://doi.org/10.1093/ckj/sfac013.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Luskin MR, Heil DS, Tan KS, Choi S, Stadtmauer EA, Schuster SJ, et al. The impact of EBV status on characteristics and outcomes of posttransplantation lymphoproliferative disorder. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2015;15(10):2665–73. https://doi.org/10.1111/ajt.13324.

Article  CAS  Google Scholar 

Nelson BP, Nalesnik MA, Bahler DW, Locker J, Fung JJ, Swerdlow SH. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol. 2000;24(3):375–85. https://doi.org/10.1097/00000478-200003000-00006.

Article  CAS  PubMed  Google Scholar 

Quinlan SC, Pfeiffer RM, Morton LM, Engels EA. Risk factors for early-onset and late-onset post-transplant lymphoproliferative disorder in kidney recipients in the United States. Am J Hematol. 2011;86(2):206–9. https://doi.org/10.1002/ajh.21911.

Article  PubMed  PubMed Central  Google Scholar 

Al-Mansour Z, Nelson BP, Evens AM. Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies. Curr Hematol Malig Rep. 2013;8(3):173–83. https://doi.org/10.1007/s11899-013-0162-5.

Article  PubMed  PubMed Central  Google Scholar 

Sprangers B, Riella LV, Dierickx D. Posttransplant lymphoproliferative disorder following kidney transplantation: a review. Am J Kidney Dis. 2021;78(2):272–81. https://doi.org/10.1053/j.ajkd.2021.01.015.

Article  PubMed  Google Scholar 

Serre JE, Michonneau D, Bachy E, Noël LH, Dubois V, Suberbielle C, et al. Maintaining calcineurin inhibition after the diagnosis of post-transplant lymphoproliferative disorder improves renal graft survival. Kidney Int. 2014;85(1):182–90. https://doi.org/10.1038/ki.2013.253.

Article  CAS  PubMed  Google Scholar 

Coiffier B, Sarkozy C. Diffuse large B-cell lymphoma: R-CHOP failure-what to do? Hematology Am Soc Hematol Educ Program. 2016;2016(1):366–78. https://doi.org/10.1182/asheducation-2016.1.366.

Article  PubMed  PubMed Central  Google Scholar 

William BM, Bongu NR, Bast M, Bociek RG, Bierman PJ, Vose JM, et al. The utility of lactate dehydrogenase in the follow up of patients with diffuse large B-cell lymphoma. Rev Bras Hematol Hemoter. 2013;35(3):189–91. https://doi.org/10.5581/1516-8484.20130055.

Article  PubMed  PubMed Central  Google Scholar 

Fasola G, Fanin R, Gherlinzoni F, Galieni P, Taruscio D, Frezza G, et al. Serum LDH concentration in non-Hodgkin’s lymphomas. Relationship to histologic type, tumor mass, and presentation features. Acta Haematol. 1984;72(4):231–8. https://doi.org/10.1159/000206395.

Article  CAS  PubMed  Google Scholar 

The International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. New Engl J Med. 1993; 329(14):987–94. https://doi.org/10.1056/nejm199309303291402.

Article  Google Scholar 

Banerjee M, Singh R, Arora MM, Srinivas V, Basannar D, Patrikar S. Biomarkers of malignant ascites-a myth or reality. Med J Armed Forces India. 2011;67(2):108–12. https://doi.org/10.1016/s0377-1237(11)60005-1.

Article  PubMed  PubMed Central  Google Scholar 

Boyer TD, Kahn AM, Reynolds TB. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels. Arch Intern Med. 1978;138(7):1103–5.

Article  CAS  PubMed  Google Scholar 

Belay Y, Yirdaw K, Enawgaw B. Tumor lysis syndrome in patients with hematological malignancies. J Oncol. 2017;2017:9684909. https://doi.org/10.1155/2017/9684909.